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Herpesvirus saimiri (HVS)-transformed T-lymphocytes are permissive for both X4 and R5 strains of human immunodeficiency virus type
1 (HIV-1). HVS-encoded proteins tyrosine-kinase interacting protein (Tip) and saimiri transformation-associated protein subgroup C (StpC)
were previously implicated in altering HIV permissiveness. MOLT4 cells expressing StpC or StpC and Tip are permissive for X4 strains of
HIV-1. In contrast, HIV-1 was restricted in MOLT4 cells expressing Tip alone. Here we show that MOLT4 cells and primary lymphocytes
expressing StpC are permissive for R5 strains of HIV-1 while Tip expression restricted R5 strains. These results suggest that intracellular
immunization with Tip and StpC could be developed as models for therapeutic strategies targeting both X4 and R5 strains of HIV-1.
D 2004 Elsevier Inc. All rights reserved.Keywords: Herpesvirus saimiri; HIV-1; Viral tropism; T-cellIntroduction
Human peripheral blood T-lymphocytes have been suc-
cessfully transformed in vitro by infection with Herpesvirus
saimiri (HVS) subgroup C strains (Biesinger et al., 1992).
HVS-transformed T-cell lines retain properties of normal T-
cells including antigen specificity and a mature activated
phenotype (Bro¨ker et al., 1993). As a result, HVS-trans-
formed T-cells have been used as a model to study T-cell
biology (Meinl and Hohlfeld, 2000). In that regard, HVS-
transformed T-cells are highly permissive for both T-tropic
(X4) (Nick et al., 1993; Saha et al., 1997; Vella et al., 1997)
and M-tropic (R5) strains of human immunodeficiency virus
type 1 (HIV-1) (Vella et al., 1999). HVS-immortalized human
lymphocytes have been utilized for the isolation, propaga-
tion, and analysis of diverse strains of HIV-1 (Vella et al.,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: eehender@temple.edu (E.E. Henderson).2002). Evidence has accumulated that saimiri transformation-
associated protein subgroup C (StpC) and tyrosine-kinase
interacting protein (Tip), two unique proteins of subgroup C,
are responsible for the permissive phenotype of HVS-trans-
formed T-cells. Tip and StpC are required for HVS-induced
transformation and are translated from a bicistronic RNA
message (reviewed in Tsygankov and Romano, 1999).
MOLT4 cells retrovirally transduced to express StpC are
permissive for X4 strains of HIV-1, whereas Tip expression in
MOLT4 dramatically restricted the replication of X4 strains
of HIV-1 (Henderson et al., 1999). In double transductants,
the StpC phenotype was dominant and thus consistent with
the observation that HVS-transformed T-cells are permissive
for HIV-1. The ability of Tip and StpC to modulate the
replication of X4 strains of HIV-1 suggested that therapeutic
strategies targeting HIV-1 could be modeled on the ectopic
expression of Tip or StpC, or both. However, therapeutic
strategies targeting HIV-1 would need to inhibit both X4 and
R5 strains of HIV-1 to be effective. For example, a strategy
designed to target HIV-1 based on inhibiting gp120-mediated
signal transduction in T-lymphocytes restricted replication of
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ness (Popik and Pitha, 2000). In this report, we show that Tip
and StpCmodulate the replication of R5 as well as dual tropic
strains of HIV-1 in a manner similar to that observed for X4
strains of HIV-1, and could be developed as models for
therapeutic strategies. Therapeutics effecting both X4 and
R5 strains of HIV would be extremely advantageous, since
there is a direct correlation between the phenotypic switch
from R5 to X4 tropism and increased HIV-1 pathogenesis
(Glushakova et al., 1998).Results
Tip and StpC affect replication of M-tropic (R5) and dual
tropic strains of HIV-1
MOLT4 transduced with murine stem cell virus
(MSCV)-based vectors encoding Tip and/or StpC (Merlo
et al., 1998) were used to study the effects of theseFig. 1. Replication of R5 strains of HIV-1 (Ba-L and SF162) in MOLT4 cells trans
p24 by ELISA were measured 7 days following infection. PN = Pac/Neo; TN
transductants) are denoted as follows: C2 = StpC/Tip/PN clone C2; D2 = StpC/Tip
infected pac-, neo-, or Tip-transduced MOLT4 cells were used to infect PBMCs. V
measuring p24 antigen levels in culture supernatants using a capture ELISA. HIV-1
with supernatants from MOLT4 transduced with pac/neo or StpC-pac/neo then inf
supernatants was determined using p24 ELISA 10 days post infection. *P < 0.05proteins on the replication of R5 strains of HIV-1. When
compared to control cells transduced with the empty
vectors (pac/neo), Tip-expressing cells exhibit approxi-
mately a 10-fold restriction in the replication of R5 strains
of HIV-1, as measured by syncytia formation and the
accumulation of p24 in culture supernatants (Fig. 1A).
Consistent with these results, HIV-1-induced cytopathic
effects (CPE) were ameliorated 10-fold and cell survival
enhanced 14- to 20-fold by Tip expression (Table 1). In
contrast, StpC-expressing cells exhibited a 3- to 6-fold
increase in p24 production and syncytia as well as greatly
increased CPE and reduced survival when compared to
MOLT4 cells transduced with empty vector alone (Fig.
1A; Table 1). In MOLT4 clones expressing both Tip and
StpC, the StpC phenotype dominated, consistent with the
observation that HVS-transformed T cells are highly per-
missive for R5 strains of HIV-1. We examined whether the
ability of Tip and StpC to affect HIV-1 infection in
transduced MOLT4 cells could be explained by changes
in the expression of HIV-1 receptor or coreceptors. Flowduced to express Tip and/or StpC. (A) Syncytia (insert) and accumulation of
= Tip/Neo; SP = StpC/Pac. Clones expressing both StpC and Tip (dual
/PN clone D2; D3 = StpC/Tip/PN clone D3. (B) Culture supernatants from
iral replication in PBMCs was monitored following 10 days of infection by
strains were used: Ada-M and JRFL. *P < 0.05. (C) PBMCs were infected
ected with Ada-M or JRFL. Accumulation of p24 antigen in PBMC culture
determined by Student’s t test (n = 3).
Table 1
Colony formation by Molt4 cells transduced with StpC, Tip, or StpC and
Tip following infection with R5 stains of HIV-1
Cell lines Percentage colony-forming ability as measured by
limiting dilution:
Mock SF162 Bal
Single transductants
Molt4 Pac/Neo >90 5.0 2.5
Molt4 Tip,
Pac/Neo
>90 70 20
Molt4 StpC,
Pac/Neo
>90 0.001 V0.0001
Double transductants
Molt4 StpC/
Tip C2
>90 0.001 V0.0001
Molt4 StpC/
Tip D3
>90 0.001 0.001
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Tip did not reveal significant differences in the mean
fluorescent intensity (MFI) or the percent of cells positive
for CD4, CCR5, or CXCR4 surface expression that would
explain the significant differences in susceptibility to HIV-
1 infection observed (data not shown).
Expression of R5 strains of HIV-1 in latently infected
MOLT4 clones expressing Tip or StpC
The survival of HIV-1-infected MOLT4 cells expressing
Tip is significantly increased more than that of MOLT4Fig. 2. Tip and StpC expression in PBMCs modulates HIV infection. (A) Expressio
in PBMCs following transduction with lentiviral vectors driving the expression o
SupT1. * = Significantly different from cells transduced with matched control ancells transduced with empty vector alone and surviving
colonies are easily established (Table 1). In contrast,
MOLT4 cells expressing StpC rarely survive infection
with R5 strains of HIV-1. However, it is possible to
establish cell lines from HIV-infected MOLT4 cells
expressing StpC, albeit at a low frequency (Table 1).
Clones established from Tip- and StpC-expressing MOLT4
cells, which survived HIV-1 infection, harbor HIV-1
proviral DNA (data not shown). To further assess the
virological parameters in these surviving clones, cell-free
supernatants were analyzed for infectious virus. Infectious
HIV-1 released by MOLT4 transduced to express Tip was
reduced 70.5–99.9% when compared to MOLT4 cells
transduced with empty vector (Fig. 1B). In contrast, there
was a 3- to 11-fold increase in infectious virus released
from surviving clones of MOLT4 transduced with StpC
when compared to surviving clones transduced with the
empty vectors (pac/neo) alone (Fig. 1C).
Transduction of peripheral blood mononuclear cells
(PBMCs) with Tip or StpC altered replication of both X4
and R5 strains of HIV-1
Using a lentiviral vector system, efficient expression of
both Tip and StpC was achieved in MOLT4 cells and
nonimmortalized lymphocytes (Hasham and Tsygankov,
2004). To determine whether expression of Tip and StpC
in lymphocytes affects HIV-1 replication, PBMCs were
transduced to express Tip or StpC (Fig. 2A) and thenn of Tip and StpC in PBMCs. (B) Infected-centers assay: HIV-1 replication
f Tip or StpC as measured by syncytia formation following co-culture with
tibiotic selection vectors. P < 0.05.
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sion inhibited virus-induced CPE 2-fold as measured by
syncytia induction, while StpC-expression induced a 10-
fold enhancement of syncytia induction by PBMCs (Fig.
2B). We did not observe phenotypic changes in uninfected
T-cells transduced with lentiviral vectors encoding StpC or
Tip.
Replication of HIV-1 is modulated in human umbilical cord
blood leukocytes (HUCLs) transduced with lentiviral
vectors encoding Tip or StpC
Potential therapeutic applications of Tip and/or StpC may
involve the use of progenitor cells derived from HUCLs. To
this end, HUCLs were transduced with lentiviral vectors
encoding Tip or StpC, placed on antibiotic selection, and
then enriched for either lymphocytes or monocytes by
culturing in medium containing IL-2 and M-CSF, respec-
tively. The enriched cells were then infected with either X4
or R5 strains of HIV-1. Replication of R5 strains of HIV-1
was quantitated in enriched monocytes and T-cells derived
from HUCLs transduced with lentiviral vectors encoding
Tip or StpC. R5 and X4 strains of HIV-1 were restricted in
cells derived from Tip-transduced HUCLs (Figs. 3A,B).
Cells derived from StpC-transduced HUCL were permissive
for R5 and X4 strains of HIV-1 (Figs. 3C,D). These results
show that expression of Tip and StpC can modulate repli-
cation of both X4 and R5 strains of HIV-1 in primary
lymphocytes.Fig. 3. Effects of HVS-Tip and StpC on X4 and R5 HIV-1 replication in HUCL
supernatant of infected human umbilical cord blood-derived macrophage at da
lymphocytes (A, C) and HUCL-derived macrophage (B, D) were transduced with
then infected with RF or SF162. * = Statistical significance determined using StuDiscussion
Tip and StpCmodulated replication of R5 strains of HIV-1
in MOLT4, PBMCs, and HUCL-derived cells in a manner
similar to that observed for X4 strains. Replication of R5
strains of HIV-1 in Tip-transduced MOLT4 and primary cells
was dramatically restricted, as measured by p24 antigen and
syncytia formation. Tip expression significantly increased
cell survival of HIV-1-infected cells and lowered both the
production of infectious virus and syncytia in surviving
clones. In contrast, replication of R5 strains of HIV-1 was
dramatically enhanced in MOLT4, PBMCs, and HUCL-
derived cells expressing StpC. The mechanism whereby Tip
and StpC mediate effects on HIV-1 replication is not known.
However, we posit that the dichotomous effects of Tip and
StpC on HIV-1 replication are due to differences in how these
HVS-encoded proteins affect signal transduction pathways
critical to the HIV-1 life cycle. Studies have shown that both
Tip and StpC interact with various components of T-cell
signaling pathways (reviewed in Tsygankov and Romano,
1999). StpC activates Ras and NF-nB signaling pathways
(Guo et al., 1998; Jung and Desrosiers, 1995). Both Ras-
activated AP-1 and NF-nB transcription factors have been
shown to up-regulate expression of the HIV-1 LTR (Rohr et
al., 2003). These findings are consistent with the effects of
StpC on HIV-1 replication.
Tip-mediated restriction of HIV-1 replication could be a
result of Tip interaction with Lck, a T-cell-specific protein
tyrosine kinase, which is critical for T-cell activation.-derived monocytes and T-lymphocytes. Concentration of p24 released in
ys 14 and 21 was determined using p24 capture ELISA. HUCL-derived
Neo, Tip/Neo, Pac, or StpC/Pac vectors, placed on selection for 7 days, and
dent’s t test. P < 0.05.
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and up-regulates Lck activity (Biesinger et al., 1995;
Wiese et al., 1996). However, a reduction in Lck activity
in Tip-transduced Jurkat T-cells has also been reported
(Guo et al., 1997). Tip-expressing MOLT4 cells used in
our study did not display significant alterations in Lck
activity but showed a dramatic increase in overall protein
tyrosine phosphorylation (Merlo et al., 1998).
Here, we report that replication of X4 and R5 strains of
HIV-1 are modulated by StpC and Tip in the same manner;
StpC enhanced, whereas Tip restricted viral replication. This
is advantageous, because the ectopic expression of these
proteins in immune cells could be developed as models for
therapeutic strategies against both M-and T-tropic strains of
HIV-1. For example, Tip-expressing T-cells would potential-
ly be protected from the cytopathic effects of HIV-1. StpC
expression vectors could be utilized to induce replication-
competent reservoirs sensitizing them to high activity anti-
retroviral therapy (HAART). Since wild-type and quasi-
species of HIV-1 R5 and X4 variants persist during pro-
longed antiretroviral drug therapy (van Rij et al., 2002), it is
imperative that novel therapies directed against HIV-1 be
effective against R5 and X4 strains. Here we demonstrate
that the ectopic expression of Tip and StpC can modulate the
replication of R5 and X4 strains of HIV-1.Materials and methods
Engineering CD4+ T-cell lines stably expressing Tip, StpC,
or both Tip and StpC
MOLT4 cells were obtained from American Type Cul-
ture Collection and transduced to express Tip or StpC
using the murine stem cell virus (MSCV)-based gene
transfer system (Merlo et al., 1998). Briefly, MOLT4 cells
transduced with MSCV-based retroviral vectors driving the
expression of Tip or StpC and the corresponding control
vectors were cloned by antibiotic selection and subsequent
limiting dilution. Single-transductant clones were selected
for pac or StpC/pac expression with puromyocin (1 Ag/ml).
Clones expressing neo or Tip/neo were selected using
G418 (200 Ag/ml). ‘‘Double-transductants’’ were produced
by consecutively transfecting cells with two retroviral
vectors carrying different antibiotic selection markers.
Three cell types (neo/pac, neo/StpC-pac, and neo/Tip-
pac) were represented in this study by a single clone.
Tip+StpC+ cells (Tip-neo/StpC-pac) were represented by
two individual clones.
Generation of Tip/neo or StpC/pac pseudo-virus
Pseudo-viruses carrying the Tip/neo or StpC/pac genes
were produced as previously described (Hasham and
Tsygankov, 2004) and either used immediately or stored
at –80 jC.Transduction of PBMCs and HUCLs with lentiviral vectors
driving Tip or StpC expression
PBMCs were prepared from normal blood donors using
Ficoll-hypaque (Pharmacia Biotech, Piscataway, NJ). Isolat-
ed PBMCs were cultured at densities between 1  106 and
2 106 cells per milliliter in RPMI-1640 supplemented with
10% heat-inactivated fetal bovine serum and antibiotics
(complete medium). Human umbilical cord leukocytes were
isolated from umbilical cord blood using Ficoll-hypaque,
diluted in complete medium, and seeded in 24-well tissue
culture plates at a density of 1 106 cells per milliliter. Plated
cells were transduced with 100 Al of lentiviral vector super-
natants prepared as described in (Hasham and Tsygankov,
2004) to express either pac only, neo only, StpC and pac, or
Tip and neo. Following a 48-h period, the viral vectors were
removed, and cells were placed on antibiotic selection. Cells
transduced with neo-or tip/neo-vectors were grown in media
containing G418 (200 Ag/ml). Pac-or stpC/pac-transduced
cells were grown in media containing 1 Ag/ml of puromycin
and were added to the growth media. HUCL transductants
were simultaneously enriched for T-lymphocyte and mono-
cyte populations by adding cytokines IL-2 (100 ng/ml) and
M-CSF (100 ng/ml) to the HUCL culture media, respectively.
Transductants were placed on selection/enrichment for 7 days
before infection with either R5 or X4 strains of HIV-1.
Source and propagation of X4 and R5 strains of HIV-1
All handling of vector transductions were carried out in the
Biological Safety Level 2 facility at Temple University
School of Medicine using standard safety precautions. T-
tropic (X4) strains (IIIB and RF) and theM-tropic (R5) strains
(Ada-M, Ba-L, JRFL, and SF162) were obtained from the
AIDS Research and Reference Reagent Program (Division of
AIDS, NIAID, Rockville, MD). X4 strains were propagated
in MOLT4 4 cells, whereas primary cultures of normal
PBMCs were used to propagate R5 strains. To eliminate
soluble components, viruses were purified from culture
supernatants by ultracentrifugation at 33000 rpm for 1 h at
4jC in a Ti60 rotor. Pellets were collected, gently washed in
PBS, and resuspended in 1 ml complete medium per 50 ml of
supernatant. Concentrated virus was filtered through a 0.8-
Am filter and then stored at70 jC. X4 HIV-1 was titered on
SupT1 cells by syncytia formation. Stocks ranged from 106 to
107 syncytia-forming units per 1 ml. R5 strains were titered
using limiting dilutions followed by p24 analysis to deter-
mine the highest dilution giving rise to p24 values equal to 10
infectious units per milliliter.
Quantification of HIV-1 replication in Tip- or
StpC-transduced cell lines and primary lymphocytes
Syncytia formation
The infected-centers assay was used to measure syncytia
formation. Briefly, transduced cells were incubated with the
gy 324 (2004) 60–66
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Infected cells were washed, serially diluted, and mixed with
2  105 SupT1 indicator cells. Syncytia were scored in
triplicate using an inverted scope 96 h post mixing with the
indicator cells.
Measuring p24 core antigen
Aliquots of infected cell culture supernatants were col-
lected at 4, 7, 14, and 21 days post infection and stored at
80 jC. Viral concentrations were determined by a p24-
specific capture enzyme-linked immunosorbent assay
(ELISA) kit (SAIC-Frederick, Frederick, MD).
Immunoprecipitation and Western blotting
Immunoprecipitation and Western blotting to detect Tip
and StpC expression were performed as previously de-
scribed (Merlo et al., 1998). Briefly, StpC-transductants
were lysed in Tris/NaCl/EDTA (TNE) buffer containing
1% NP40 and 10 AM of aprotonin and leupeptin protease
inhibitors. StpC was detected by immmunoblotting of whole
cell lysates (100 Ag of total protein per lane). Lysates were
separated using SDS-PAGE and transferred to a nitrocellu-
lose membrane that was probed with anti-StpC sera. StpC
was then visualized using chemiluminescence visualized on
X-ray.
Tip was detected using the in vitro kinase assay. Cell
lysates containing 0.5–1 mg of total protein was subjected
to immunoprecipitation using anti-Tip sera and PANSOR-
BIN. Resulting precipitates were extensively washed and
then incubated in kinase buffer containing [g-32P] ATP
(NEN, Boston, MA) for 20 min. Reactions were stopped
by adding SDS-PAGE sample buffer. Phosphorylated pro-
teins were separated using SDS-PAGE and visualized by
autoradiography.
Statistical analysis
Statistical significance (P < 0.05) was determined using
Student’s t test comparisons between cells transduced with
either empty or Tip/StpC vectors.Acknowledgments
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